Influence of a Dopamine Pathway Additive Genetic Efficacy Score on Smoking Cessation: Results from Two Randomized Clinical Trials of Bupropion

AIMS: To evaluate associations of treatment and an ‘additive genetic efficacy score’ (AGES) based on dopamine functional polymorphisms with time to first smoking lapse and point prevalence abstinence at end of treatment among participants enrolled in two randomized clinical trials of smoking cessati...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: David, Sean P., Strong, David R., Leventhal, Adam M., Lancaster, Molly A., McGeary, John E., Munafò, Marcus R., Bergen, Andrew W., Swan, Gary E., Benowitz, Neal L., Tyndale, Rachel F., Conti, David V., Brown, Richard A., Lerman, Caryn, Niaura, Raymond
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3834197/
https://ncbi.nlm.nih.gov/pubmed/23941313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/add.12325
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller